Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123814584 | 12381458 | 4 | F | 20160329 | 20160816 | 20160518 | 20160826 | EXP | JP-OTSUKA-2016_007941 | OTSUKA | 76.23 | YR | M | Y | 58.00000 | KG | 20160826 | PH | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123814584 | 12381458 | 1 | PS | SAMSCA | TOLVAPTAN | 1 | Oral | 7.5 MG, QD | 135 | MG | U | 22275 | 7.5 | MG | TABLET | QD | |||
123814584 | 12381458 | 2 | SS | SAMSCA | TOLVAPTAN | 1 | Oral | 15 MG, QD | 135 | MG | U | 22275 | 15 | MG | TABLET | QD | |||
123814584 | 12381458 | 3 | SS | SAMSCA | TOLVAPTAN | 1 | Oral | 15 MG, DAILY DOSE | 135 | MG | U | 22275 | 15 | MG | TABLET | ||||
123814584 | 12381458 | 4 | SS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous drip | 13.5 G, DAILY DOSE | U | 0 | 13.5 | G | INJECTION | ||||||
123814584 | 12381458 | 5 | SS | HANP | CARPERITIDE | 1 | Intravenous drip | 2000 ?G, DAILY DOSE | U | 0 | 2000 | UG | INJECTION | ||||||
123814584 | 12381458 | 6 | SS | HANP | CARPERITIDE | 1 | Intravenous drip | UNK | U | 0 | INJECTION | ||||||||
123814584 | 12381458 | 7 | SS | HANP | CARPERITIDE | 1 | Intravenous drip | 2000 ?G, DAILY DOSE | U | 0 | 2000 | UG | INJECTION | ||||||
123814584 | 12381458 | 8 | C | FERROUS SODIUM CITRATE | SODIUM FERROUS CITRATE | 1 | Oral | 200 MG, DAILY DOSE | 0 | 200 | MG | FILM-COATED TABLET | |||||||
123814584 | 12381458 | 9 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Oral | 20 MG, DAILY DOSE | 0 | 20 | MG | TABLET | |||||||
123814584 | 12381458 | 10 | C | FRANDOL | ISOSORBIDE DINITRATE | 1 | Transdermal | 40 MG, DAILY DOSE | 0 | 40 | MG | TRANSDERMAL PATCH | |||||||
123814584 | 12381458 | 11 | C | BFLUID | AMINO ACIDSDEXTROSEELECTROLYTES NOSVITAMINS | 1 | Intravenous drip | UNK | 0 | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123814584 | 12381458 | 1 | Pleural effusion |
123814584 | 12381458 | 2 | Fluid retention |
123814584 | 12381458 | 4 | Product used for unknown indication |
123814584 | 12381458 | 5 | Product used for unknown indication |
123814584 | 12381458 | 8 | Product used for unknown indication |
123814584 | 12381458 | 9 | Product used for unknown indication |
123814584 | 12381458 | 10 | Product used for unknown indication |
123814584 | 12381458 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123814584 | 12381458 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123814584 | 12381458 | Blood albumin decreased | |
123814584 | 12381458 | Blood urea increased | |
123814584 | 12381458 | Hypernatraemia | |
123814584 | 12381458 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123814584 | 12381458 | 1 | 20160316 | 20160317 | 0 | |
123814584 | 12381458 | 2 | 20160318 | 20160329 | 0 | |
123814584 | 12381458 | 3 | 20160422 | 0 | ||
123814584 | 12381458 | 4 | 20160325 | 20160402 | 0 | |
123814584 | 12381458 | 5 | 20160315 | 20160319 | 0 | |
123814584 | 12381458 | 6 | 20160402 | 0 | ||
123814584 | 12381458 | 7 | 20160424 | 20160424 | 0 | |
123814584 | 12381458 | 8 | 20160429 | 0 | ||
123814584 | 12381458 | 9 | 20160402 | 0 | ||
123814584 | 12381458 | 10 | 20160429 | 0 |